Crohn's disease: open trials in Chile

• NCT06430801

  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Hospital Clínico Regional Dr. Guillermo Grant Benavente (Site 2604), Concepción · Clínica Universidad de Los Andes (Site 2609), Las Condes · Clínica Alemana de Santiago-Unidad de Investigaciones (Site 2602), Santiago · FALP-UIDO (Site 2600), Santiago · Espacio Eme (Site 2608), Santiago · CECIM (Site 2603), Santiago · Hospital hernan henriquez aravena de temuco (Site 2607), Temuco · Centro de Investigaciones Clinicas Vina del Mar (Site 2606), Viña del Mar

  Registry updated 2026-11-02

• NCT06819891

  A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Medicina de Precisión - Celerity, Las Condes · Medwal, Santiago · Centro de Investigación Clínica UC-CICUC, Santiago

  Registry updated 2026-10-26

• NCT07184931

  An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · Sanofi

  Santiago · Santiago · Santiago · Viña del Mar

  Registry updated 2026-10-21

• NCT07184944

  A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · Sanofi

  Viña del Mar

  Registry updated 2026-10-21

• NCT06819878

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Hospital Guillermo Grant Benavente, Concepción · Clínica Universidad de Los Andes, Santiago · Medwal, Santiago

  Registry updated 2026-10-16

• NCT06758024

  PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

  Trial Treatment · Pontificia Universidad Catolica de Chile

  Pontificia Universidad Catolica of Chile, Santiago

  Registry updated 2025-02-28

• NCT06756100

  Early Inflammatory Bowel Disease Progression

  Research · Pontificia Universidad Catolica de Chile

  Pontificia Universidad Catolica of Chile, Santiago

  Registry updated 2025-01-01

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error